Share on StockTwits

Vernalis plc (LON:VER)‘s stock had its “buy” rating reaffirmed by Oriel Securities Ltd in a research note issued on Thursday. They currently have a GBX 56 ($0.95) target price on the stock. Oriel Securities Ltd’s price objective indicates a potential upside of 72.31% from the company’s current price.

Shares of Vernalis plc (LON:VER) opened at 31.66 on Thursday. Vernalis plc has a 52-week low of GBX 18.75 and a 52-week high of GBX 38.00. The stock’s 50-day moving average is GBX 31.96 and its 200-day moving average is GBX 34.7.

A number of other firms have also recently commented on VER. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Vernalis plc in a research note on Wednesday, May 14th. They now have a GBX 52 ($0.88) price target on the stock. Finally, analysts at Nplus1 Brewin reiterated a “buy” rating on shares of Vernalis plc in a research note on Thursday, April 24th. They now have a GBX 42 ($0.71) price target on the stock. Five equities research analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and an average price target of GBX 48 ($0.81).

Vernalis plc is a research and development-stage pharmaceutical company. Vernalis has one marketed product and a portfolio of development and drug discovery programmes.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.